Skip to main content
PMC home page
International Journal of Bipolar Disorders logoLink to International Journal of Bipolar Disorders
. 2020 Jun 1;8:16. doi: 10.1186/s40345-020-00181-6

Sleep and physical activity in patients with newly diagnosed bipolar disorder in remission, their first-degree unaffected relatives and healthy controls

Nikolaj Folke la Cour Karottki 1, Klara Coello 1, Sharleny Stanislaus 1, Sigurd Melbye 1, Hanne Lie Kjærstad 1, Kimie Stefanie Ormstrup Sletved 1, Lars Vedel Kessing 1,2, Maj Vinberg 1,2,3,✉
PMCID: PMC7261715  PMID: 32476067

Abstract

Background

Sleep disturbances are a central feature in bipolar disorder (BD) that often persist in remission and seem to be present also in unaffected first-degree relatives (UR) of patients with BD, presenting a possible risk factor for later onset of BD. However, it is unknown if these disturbances are associated with unhealthy life-style as reflected in low levels of physical activity. We investigated sleep disturbances and physical activity levels in patients with newly diagnosed BD in full or partial remission, their UR and healthy controls (HC).

Methods

Sleep patterns and physical activity were compared in 227 patients with newly diagnosed BD, 76 UR and 148 HC. The Pittsburgh Sleep Quality Index (PSQI) and the International Physical Activity Questionnaire (IPAQ) were used to assess sleep disturbances and physical activity, respectively.

Results

In sex- and age-adjusted analyses, patients with BD exhibited more sleep disturbances and lower physical activity compared with UR and HC, respectively. Unaffected relatives reported significantly longer sleep latency and a non-significant trend towards more overall sleep disturbances compared with HC.

Conclusions

Sleep disturbances and less physical activity are present in patients with newly diagnosed BD in partial or full remission. Individuals at familiar risk of BD reported longer sleep latency and similar physical activity compared with HC. Further prospective studies are needed to clarify whether these discrete sleep disturbances act as risk factor for later onset of BD and whether increased physical activity in high-risk individuals may act as a protective factor against development of psychiatric illness.

Keywords: Bipolar disorder, Sleep, Physical activity, Unaffected relatives

Background

Bipolar disorder (BD) is a recurrent mood disorder with episodes of depression and mania. It is often associated with functional disability, decreased quality of life and reduced life expectancy (Rosa et al. 2014; Kessing and Andersen 2017). The mean age of onset is mid to late twenties in Europe and the estimated lifetime prevalence is thought to be 1–2% (Pedersen et al. 2014; Post et al. 2008). A substantial hereditary component is seen in families of patients with BD with the approximate lifetime risk of BD in first-degree relatives being 5–10% and monozygotic co-twins 40–70% (Craddock and Sklar 2013; McGuffin et al. 2003). Studies show that up to 50% of first-degree relatives of patients with BD will develop a mood disorder or another psychiatric illness (Mesman et al. 2013; Duffy et al. 2015). However, knowledge of the specific factors that run cross generations is needed to tailor a more integrated preventive approach. Further, there is a latency of approximately 6 years from onset to initial treatment of BD (Dagani et al. 2017). Yet, early treatment seems to hinder a more severe progression of the disorder (Bender and Alloy 2011; Shapero et al. 2017; Kessing et al. 2014) and it is thus crucial to discover robust risk factors and valid biomarkers.

Central features in BD are circadian rhythm abnormalities including sleep disturbances (Gold and Sylvia 2016; Takaesu 2018) characterized by difficulty falling asleep, maintaining sleep and early morning awakening leading to dissatisfaction with sleep quantity and quality (Buysse et al. 2017). These changes in sleep pattern often persist after manic and depressive episodes and they further seem to be present in unaffected first-degree relatives (UR) of patients with BD as well, presenting a possible risk factor of developing BD (Keskin et al. 2018; Melo et al. 2016a; Ritter et al. 2015). Unaffected first-degree relatives of patients with BD might have a latent-stage or risk stage BD (Kapczinski et al. 2009, 2014; Berk et al. 2017) due to a possible shared biological underpinning. A systematic review including 30 studies and 5778 high-risk individuals (Melo et al. 2016a) showed more sleep disturbances and poor sleep quality in high-risk individuals cross-sectionally. Five prospective studies were also included (n = 3759), four of which investigated offspring of parents with BD (follow-up periods ranged from 4 to 16 years) and these revealed that poor sleep quality, trouble falling asleep, early morning awakening, night-time awakenings and inadequate sleep could be an indicator of later onset of BD (Melo et al. 2016a). This is in line with a recent review focusing on sleep alterations anticipating the onset of BD including 17 studies both prospective (n = 6) and retrospective (n = 11), concluding that sleep alterations also seem to appear long before the onset of BD. Nevertheless, sleep disturbances have not been investigated in newly diagnosed BD and their healthy first-degree relatives (Pancheri et al. 2019).

Physical activity is widely known to reduce risk of all-cause mortality, cardiovascular disease and cancer-related mortality compared to sedentary behaviour (Andersen et al. 2000; Kodama et al. 2009; Lear et al. 2017; Piercy et al. 2018) and sleep disturbances are associated with a risk of all-cause mortality and cardiovascular events (Yin et al. 2017). Bipolar disorder is associated with comorbid somatic disorders mainly cardiovascular disease, obesity and non-insulin dependent diabetes (Evans et al. 2005). Putative reasons for these conditions and the increased mortality observed in patients with BD (Correll et al. 2017) include a more sedentary lifestyle (Vancampfort et al. 2016; Kilbourne et al. 2007) as well as abnormal sleep patterns (Yin et al. 2017; Cappuccio et al. 2010). The increased cardiovascular risk seems further to be present in youth with BD (Goldstein et al. 2015) and in young adults with newly diagnosed bipolar disorder (Coello et al. 2019). Consequently, it is highly interesting to investigate physical activity and sleep patterns in BD and preceding BD by studying patients with newly diagnosed BD and their first-degree relatives.

Overall patients with BD and UR seem to express a disturbed sleep pattern, however, whether this is associated with an unhealthy life-style reflected in decreased physical activity has not previously been studied in patients newly diagnosed with BD and their UR.

This study aimed to investigate sleep disturbances (and patterns) and patterns of physical activity among patients with newly diagnosed BD in full or partial remission, UR and HC. We hypothesized that patients with BD in full or partial remission would report more sleep disturbances and less physical activity than HC and that the UR would show an intermediary pattern in both outcomes.

Materials and methods

Study design

The Copenhagen Affective Disorder Clinic is an outpatient clinic that covers the Copenhagen Capital region catchment area of 1.6 million inhabitants and offers service for patients with newly diagnosed BD. Patients referred to the Copenhagen Affective Disorder Clinic as newly diagnosed with BD or having a first episode of (hypo)mania were routinely invited to participate in the Bipolar Onset Study (BIO) (Kessing et al. 2017). In the present cross-sectional study, we compared self-reported sleep patterns and physical activity levels across the three groups (patients with BD, UR and HC). Participants were recruited from June 2015 to December 2018.

Patients with bipolar disorder

All patients with newly diagnosed BD included in the BIO study were recruited from the Copenhagen Affective Disorder Clinic, an outpatient clinic covering the entire catchment area of the Capital Region of Denmark. Inclusion criteria were newly diagnosis with an ICD-10 diagnosis of BD or single (hypo)manic episode and age 18–70.

Unaffected relatives

First-degree relatives, siblings or children, to the patients included in the BIO-study, were recruited after permission from patients with BD, aged 15–50 years, with no history of substance abuse, psychotic illness or mood disorders according to the ICD-10 diagnostic system (International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO 2016) were invited to participate upon obtaining consent from the patients.

Healthy controls

Healthy control persons matched on sex and age to the participants with BD were recruited from the Blood Bank at Rigshospitalet, Copenhagen, Denmark. Exclusion criteria included a personal or first-degree relative with a history of psychiatric disorders requiring treatment.

Psychiatric assessment

Diagnoses were confirmed using the Schedules for Clinical Assessment in Neuropsychiatry (Wing et al. 1990) and clinical assessments using the Hamilton Depression Scale-17 items (HAMD-17) (Hamilton 1960) and the Young Mania Rating Scale (YMRS) (Young et al. 1978). Only patients in remission or partial remission defined as a score ≤ 14 at the HAMD-17 and ≤ 14 at the YMRS were included in the present study. All participants completed three self-reported questionnaires: the Pittsburgh Sleep Quality Index (PSQI), the International Physical Activity Questionnaire (IPAQ) and the Copenhagen City Heart Study (CCHS) physical activity questionnaire at the day of the assessment.

Physical assessment

Lightly dressed and without shoes, height and weight was measured using a stadiometer and a calibrated floor scale.

Questionnaires

The PSQI (Buysse et al. 1989) covers the last month and includes items such as duration of sleep, sleep latency, sleep disturbances, daytime dysfunction due to sleepiness, sleep efficiency, sleep medication and perceived quality of sleep. A higher score shows worse self-evaluated sleep, and a score of ≥ 5 implies poor sleep quality.

The IPAQ short form (Craig et al. 2003) reflects physical activity the preceding 7 days and is a questionnaire to address level of physical activity and sedentary behavior. The IPAQ provides information regarding time spent in four intensity levels: (1) vigorous-intensive activity, (2) moderate-intensity activity, (3) walking and (4) sedentary. Participants were asked to recall activity level for the past 7 days. Summary measures of overall self-reported physical activity are reported as a continuous variable metabolic equivalent task (MET minutes a week), representing the energy expended during the physical activity. Higher scores correspond to higher activity.

The score is an estimated value of MET-minutes, the kilocalories that a person weighing 60 kg would expend. We then calculated the corresponding MET-minutes for everyone’s weight, using the following formula:

TotalMETminutes∗Weight60.

In accordance with the guidelines for IPAQ scoring, we truncated values above 180 min/day and excluded values exceeding 16 h/day of activity (IPAQ Group 2005).

As a secondary measurement of physical activity, we included the CCHS (Aguib and Al Suwaidi 2015) physical activity questionnaire. The CCHS is a population study of more than 24.000 men and women in Denmark, of 20 years or older with a follow-up time of 35 years. The focus is on cardiovascular disease and its risk factors including exercise. In the physical activity questionnaire used in CCHS, participants indicate one of four categories best characterizing their level of activity, ranging from less than 2 h of low activity per week to more than 4 h of strenuous activity per week.

Statistical analyses

The descriptive data were first explored for normality and categorical data were analyzed using the Chi-squared test. Continuous data was analyzed either using Student’s T-test (parametric) or Mann–Whitney U-test (nonparametric) for two independent groups. Continuous data was described as median and quartiles if the assumptions of normality were not met. Using a general linear mixed model in SPSS version 26, we compared sleep disturbances and physical activity levels across the three groups with familial relationship as random factor, accounting for the relationship between family-related individuals, and age and sex as covariates. To check for the influence of mood symptoms, we included HAMD-17 and YMRS scores and smoking (package years) as covariates in additional analyses. To avoid overcorrection, we excluded sleep items when adjusting the PSQI. The significance threshold was set at p ≤ 0.05. Spearman’s rank-order correlation for nonparametric data post hoc analyses were done between groups (patients with BD, UR and HC) to check for correlations between sleep, physical activity, age, BMI and education levels. Within the BD group, we further examined correlations with age of onset, time of untreated BD, number of episodes and medication use. Untreated BD was defined as time from first hypomanic, manic or mixed episode to time of diagnosis. Finally, we compared the physical activity levels between the three groups using the CCHS to investigate whether it would provide the same pattern as the IPAQ.

Ethical

The study protocol was approved by the Committee on Health Research Ethics of the Capital Region of Denmark (Protocol No. H-7-2014-007) and the Danish Data Protection Agency, Capital Region of Copenhagen (RHP-2015-023). All participants provided written informed consent. The study complied with the Declaration of Helsinki principles (Seoul, October 2008).

Results

Demographic and clinical characteristics

We included 451 participants, 227 patients newly diagnosed with BD in full or partial remission, 78 UR and 148 HC. The clinical and demographic variables are shown in Table 1. The age distribution was similar in the BD and HC groups (median [interquartile range]: BD = 28 [24–36] years vs. HC = 27 [24–36] years), while the UR group was younger (26 [22–31] years, p = 0.010). There were no statistically significant differences in sex distribution between the three groups. Education attainment differed statistically significantly, with HC having 16 years [15–17] vs. patients with BD 15 years [12–17] (p ≤ 0.001) of education. There were no statistically significant differences in BMI between the groups. Patients with BD had a median age of illness onset of 17 [14–22] years and the median duration of untreated BD was 3 [1–10] years.

Table 1.

Clinical and demographic variables in patients with bipolar disorder (BD), unaffected relatives (UR) and healthy controls (HC)

BD1 UR2 HC3 p-value
Number (n) 227 76 148
Age (years) 28 [24–36] 26 [22–31] 27 [24–36]

0.011–2

0.9211–3

0.282–3
Sex (Female n (%)) 135 (59.5%) 43 (56.6%) 89 (60.0%)
Alcohol (units/week) 3 [0–7] 2 [1–7] 5 [2–8]

0.9181–2

0.0001–3

0.0012–3
Smoking (package years) 1.9 [0–6.8] 0 [0–0.4] 0 [0–0]

0.0001–2

0.0001–3

0.1322–3
Education (years) 15 [12–17] 15 [13–17] 16 [15–17]

0.1651–2

< 0.0011–3

0.0692–3
BMI (kg/m2) 24.6 [22.2–27.2] 23.9 [21.5–26.4] 23.7 [22.1–26.2]

0.1081–2

0.1311–3

0.6232–3
HAM-D17 7 [3–10] 2 [0–3] 1 [0–2]

0.0001–2

0.0001–3

0.0042–3
YMRS 2 [0–5] 0 [0–2] 0 [0–2]

0.0001–2

0.0001–3

0.7082–3
Age of onset (years) 17 [14–22] – – –
Total affective episodes 12 [6–23] – – –
Illness duration (years) 9 [5–15] – – –
Untreated bipolar disorder (years) 3 [1–10] – – –
Antiepileptics 110 (52.6%) – – –
Antipsychotics 93 (44.9%) – – –
Antidepressants 102 (49.0%) – – –
Lithium 79 (38.0%) – – –
Combination treatment 2 [1–3] – – –
Open in a new tab

Continuous variables shown as median [interquartile range] and categorical values as n (%). p-values denoted as the groups between which the comparison is made. Age of onset is the age at the time of the first affective episode. Illness duration is defined as the duration between first affective episode and inclusion in the study. Untreated bipolar disorder: time from first hypomanic, manic or mixed episode to time of diagnosis

HAM-D17 Hamilton Rating Depression Scale, 17 items, YMRS Young Mania Rating Scale

1Patients with bipolar disorder (BD)

2Unaffected first-degree relatives (UR)

3Healthy control persons (HR)

As expected, HAMD-17 and YMRS scores were statistically significantly higher in the BD group compared with UR and HC (p = 0.001), and UR also had higher HAMD-17 scores (2 [0–3] vs. 1 [0–2], p = 0.004) than HC.

Sleep

Patients with BD had a total PSQI median [interquartile range] of 8 [5–11], indicating sleep disturbances even when in remission and differed statistically significantly from the UR group (5 [3–7], p  ≤ 0.001) and the HC group (4 [3–6], p ≤ 0.001), see Table 2. At item level, all the PSQI subitems significantly differed between BD and HC, see Table 2. The differences in PSQI score remained statistically significant also when adjusting for depressive and manic symptoms and when adding smoking as a covariate (results not presented in detail). Further, removing the patients with BD with HAMD17 or YMRS above seven, leaving 99 patients with BD, the results, concerning PSQI and the subitems remained almost the same (results not presented in details) except that the significant differences between patients with BD and the UR were no longer significant concerning sleep disturbances (p = 0.185) and overall sleep quality (p = 0.078).

Table 2.

Pittsburgh Sleep Quality Index (PSQI) in patients with bipolar disorder (BD), unaffected relatives (UR) and healthy controls (HC)

BD1 UR2 HC3 p-value
Total PSQI 8 [5–11] 5 [3–7] 4 [3–6]

< 0.0011–2

< 0.0011–3

0.1152–3
Duration of sleep (4) 0.0 [0–1] 0.0 [0–1] 0.0 [0–1]

0.8031–2

0.0451–3

0.0892–3
Sleep disturbances (5b − 5j) 1.0 [1–2] 1.0 [1–1] 1.0 [1–1]

< 0.0011–2

< 0.0011–3

0.3322–3
Sleep latency (2 + 5a) 2.0 [1–3] 1.0 [1–2] 1.0 [0–1]

0.0071–2

< 0.0011–3

0.0222–3
Day dysfunction due to sleepiness (8 + 9) 1.0 [1–2] 1.0 [0–1] 1.0 [1–1]

< 0.0011–2

< 0.0011–3

0.3642–3
Sleep efficiency 0.0 [0–1] 0.0 [0–1] 0.0 [0–1]

0.0121–2

< 0.0011–3

0.1262–3
Overall sleep quality (6) 1.0 [1–2] 1.0 [0–1.5] 1.0 [0–1]

0.0031–2

< 0.0011–3

0.0782–3
Needs meds to sleep (7) 1.0 [0–3] 0.0 [0–0] 0.0 [0–0]

< 0.0011–2

< 0.0011–3

0.7302–3
Open in a new tab

PSQI item number is shown in parenthesis. Higher scores equal worse outcome. p-values are denoted as the group between which the comparison is made and calculated based on mean values, using a linear mixed model. Results written as median [interquartile range]. All analyses are adjusted for age and sex

1Patients with bipolar disorder (BD)

2Unaffected first-degree relatives (UR)

3Healthy control persons (HR)

The UR group trended towards a higher median PSQI score than the HC (5 [3–7] vs. 4 [3–6], p = 0.115). Further analyses, comparing the PSQI subitems, revealed that the UR experienced longer sleep latency than HC (p = 0.022), see Fig. 1. Further, UR reported lower perceived sleep quality (p = 0.078) and shorter sleep duration (p = 0.089) than HC, however only at trend levels, see Table 2.

Fig. 1.

Fig. 1

Open in a new tab

Box plot of the subitem sleep latency from the Pittsburgh Sleep Quality Index in patients with bipolar disorder, their unaffected first-degree relatives and healthy controls. *Statistically significant at the 0.05 level

Physical activity

As can be seen from Table 3, there was a significant difference between the BD and the HC group (2093.8 [980.1–3870.1] MET-minutes vs. 3040.0 [1755.4–5353.7] MET-minutes, p = 0.020), and the UR group showed an intermediary, non-significant pattern compared to HC. The difference was mainly in the vigorous (p = 0.038) and moderate activity (p ≤ 0.001), with walking not differing between BD and HC (p = 0.717, Fig. 2). While the UR group showed an intermediary pattern when looking at median values, they had the highest mean values (median: 2533.7 [936.5–5624.0], mean: 4147.2 CI95: [3367.9–4926.4]). Sedentary behavior was significantly higher in the HC group compared with the BD and UR group. After adjusting for HAMD-17 score, we found no statistically significant differences in IPAQ score between the groups (BD vs. HC: p = 0.304, BD vs. UR: p = 0.155, UR vs. HC: p = 0.603) while the differences remained significant when adjusting for YMRS score (BD vs. HC: p = 0.008, BD vs. UR: p = 0.012, UR vs. HC p = 0.689).

Table 3.

International Physical Activity Questionnaire (IPAQ) and the physical activity questionnaire from the Copenhagen City Heart Study (CCHS) in patients with bipolar disorder (BD), unaffected relatives (UR) and healthy controls (HC)

BD1 UR2 HC3 p-value
Vigorous activity (MET-minutes/week) 0 [0–1420] 443.3 [0.0–1781.0] 955.2 [0.0–2000.0]

0.1871–2

0.0381–3

0.7472–3
Moderate activity (MET-minutes/week) 336.6 [0.0–1012.0] 632.8 [70.8–1464.0] 1021.2 [449.4–1568.0]

0.0081–2

< 0.0011–3

0.5312–3
Walking (MET-minutes/week) 603.4 [168.3–1582.4] 556.38 [79.1–1441.44] 656.7 [260.0–1568.0]

0.2871–2

0.7171–3

0.4642–3
Sedentary (minutes/day) 300.0 [60.0–480.0] 360 [157.5–480.0] 420.0 [300.0–540.0]

0.7491–2

< 0.0011–3

0.0202–3
Total IPAQ exercise (MET-minutes/week) 2093.8 [980.1–3870.1] 2533.7 [936.5–5624.0] 3040.0 [1755.4–5353.7]

0.0281–2

0.0201–3

0.7132–3
Copenhagen city heart study 3 [2–3] 3 [3–3] 3 [3–3]

0.0001–2

0.0001–3

0.5052–3
Open in a new tab

Results written as median [interquartile range]. All analyses are adjusted for age and sex

MET metabolic equivalent of task, a measure for energy expenditure

1Patients with bipolar disorder (BD)

2Unaffected first-degree relatives (UR)

3Healthy control persons (HR)

Fig. 2.

Fig. 2

Open in a new tab

Box plot of three subitems from the International Physical Activity Questionnaire, namely walking, moderate activity and vigorous activity patients with bipolar disorder, their unaffected first-degree relatives and healthy controls. *Statistically significant at the 0.05 level

When removing all participants with HAMD17 and YMRS above 7, the difference between patients with BD and HC on total IPAQ were no longer statistically significant (p = 0.43), neither were the subitems vigorous activity (p = 0.350) and sedentary (p = 0.137). However, the patients with BD still had significantly lower scores on moderate activity (p = 0.044) and on the total Copenhagen City Hearth Study score (p = 0.001).

Post-hoc analyses

In post hoc analyses, no significant correlations between sleep and exercise when looking at total scores were found. Comparing all subitems of the PSQI and the IPAQ there was a significantly significant statistical correlation between moderate physical activity and total PSQI score (rho = − 0.174, p ≤ 0.001), so more physical activity was correlated with fewer sleep disturbances. Looking separately at patients with BD, a similar however not statistically significant correlation was found between total PSQI and IPAQ (rho = − 0.118, p = 0.096). In the patient group, we further showed a positively significant correlation between HAMD-17 and PSQI (rho = 0.412, p ≤ 0.001) and a negatively significant correlation between HAMD17 and IPAQ (rho = − 0.243, p ≤ 0.001), also when removing the sleep items. Finally, YMRS without sleep items had a significantly positively correlation with total PSQI score (rho = 0.213, p = 0.001), but not with IPAQ.

When investigating the group of patients with BD, we found that age of onset was statistically significantly correlated with total PSQI score (rho = − 0.278, p = 0.0001), pointing towards more sleep disturbances the younger the age of onset. Time with untreated BD was significantly or near-significantly correlated to both PSQI (rho = 0.123, p = 0.081) and IPAQ (rho = 0.150, p = 0.033). The number of previous affective episodes correlated positively with both PSQI (rho = 0.185, p = 0.008) and IPAQ (rho = 0.141, p = 0.043) thus more episodes were correlated with more sleep disturbances and less physical activity.

Discussion

The present study reported data on sleep disturbances and levels of physical activity from a large sample of patients with newly diagnosed BD in remission or partial remission (n = 227), their UR (n = 76) and HC (n = 148). In accordance with our hypotheses, patients with newly diagnosed BD revealed more sleep disturbances and lower physical activity than the HC. This shows that at the time of diagnosis, patients with bipolar disorder experience sleep disturbances also when they are in partial or full remission. Further, in accordance with our hypothesis, activity levels and sleep disturbances in UR showed an intermediary pattern nonetheless, only the PSQI subitem “sleep latency” differed statistically significantly between UR and HC.

When looking at physical activity we initially found significant differences between BD and UR and between BD and HC, respectively. This was supported by similar differences in the results from the physical exercise questionnaire from the CCHS (Aguib and Al Suwaidi 2015). No differences were identified regarding UR vs. HC. The variance of IPAQ scores in the UR group was larger than among the HC and our lack of findings in this group could be due to the moderate number of participants in the UR group. After adjusting for subsyndromal mood symptoms, the statistically significant differences between patients with BD and HC was reduced to a trend level. This is in line with the statistically significant correlations seen between HAMD-17 and total PSQI and IPAQ scores, pointing towards the impact of having subsyndromal symptoms, thus more depressive symptoms seem to translate into less physical activity and more sleep disturbances. More physical activity seems to impact sleep in a beneficial manner and may be part of the reason why patients with BD exhibit more sleep disturbances.

Surprisingly, the BD group showed the lowest amount of sedentary behavior in contrast to what earlier studies have found (Vancampfort et al. 2016). A partial explanation could be due to actual absence from work or school (at the time of assessment) due to sick leave, in patients with BD. In accordance with prior observations (Kantomaa et al. 2016), we conducted a post hoc correlation analysis and saw a positive correlation between sedentary behavior and educational attainment (rho = 0.187, p ≤ 0.001). Another explanation could be that the BD group underreported their sedentary behaviour, either due to unrealistic ideas about how much they sit or not wanting to reinforce the stigma of living with mental illness (Vancampfort et al. 2017). Thus, the lower reported sedentary behavior in the BD group may be due to inaccurate self-reporting of sedentary activity.

In post hoc correlation analyses we would have expected that more sleep disturbances would be correlated with less physical activity, but this was not the case when looking at total scores in the present sample. Interestingly, we found a negative correlation between moderate physical activity and total PSQI score, suggesting that moderate physical activity could be beneficial for sleep quality. Especially depressive episodes are thought to have beneficial effects from physical activity and this may also be the case for manic episodes, even though the area still lacks well-designed randomized controlled trials (Melo et al. 2016b). In our sample, patients with BD present with a low amount of moderate to vigorous activity, possibly accounting partially for their increased amount of sleep disturbances and their overall higher depression scores.

In a similar study, however not comprising newly diagnosed BD, including 107 patients with BD type I, 74 UR and 80 HC, UR reported longer sleep duration and later time of sleep than HC (Verkooijen et al. 2017). In their case, differences between groups were fully attributed to differences in mood symptoms, and group differences disappeared when adjusting for HAMD-17 and YMRS scores. As stated above, sleep latency remained statistically significantly longer among UR compared with HC in our study, when performing a similar adjustment. Looking at prospective studies of BD offspring four studies have been conducted and over all poor sleepers including those with insomnia predicted onset of BD (Pancheri et al. 2019).

When stating these differences in psychical activity and sleep patterns the impact of medication in the BD group must be considered, as most of the patients received medication at the time of the assessment (87.3%). The medication can unpredictably influence the results in the BD group. Many psychotropic drugs have either sedative or excitatory effects and may affect the amount of physical exercise and sleep. However, the UR group can be observed without the influence of medical treatment.

Sleep disturbances and physical activity in unaffected relatives

Judging from the hereditability of BD, we would expect around 30–40% of the UR to develop psychiatric illness. If sleep disturbances act as a risk marker for onset of psychiatric illness, we would expect a higher average on the PSQI within the UR group. Our results show that the UR had a trend (p = 0.072) towards reporting more overall sleep disturbances than the HC and reported significantly longer sleep latency, pointing towards that sleep disturbances seems to be a risk or even a trait factor. Two studies including prospective data on high-risk participants (Ritter et al. 2015; Levenson et al. 2015) showed that sleep disturbances seem to be a prognostic indicator of the development of BD in high-risk youth. However, more prospective studies are needed to establish discrete sleep disturbances as risk factor for later onset of BD. Physical activity seems as stated to reduce risk of all-cause mortality thus an increased physical activity in high-risk individuals may act as a protective factor against development of psychiatric illness. Here, the UR group exhibited an intermediary level of physical activity and it is not possible from the present cross-sectional design to pinpoint whether physical activity acts as a protective factor. Nevertheless, the results also point towards that physical exercise have a beneficial impact on sleep, which can be useful as a clinical advice.

Strengths

First, we recruited a relatively large sample of patients newly diagnosed with BD, their UR and HC. Second, our BD population is recruited from the Copenhagen Affective Disorder Clinic, covering the entire Capital Region of Denmark that offers treatment for patients with newly diagnosed BD. Despite this unique possibility to recruit patients with BD early in their illness course, our findings of illness duration (9 years) and untreated BD (3 years) shows the well-known diagnostic delay in accurately diagnosing BD (Baldessarini et al. 2007). Third, our study profited from high validity of the BD diagnosis, as all patients were initially assessed by a physician specialized in BD and the diagnosis was confirmed by Ph.D. students with a MD or master’s in psychology degree upon inclusion. Fourth, by including first-degree relatives, we provide insight to features possibly preceding BD.

Limitations

Several limitations must be considered when evaluating our study. First, the HC population was recruited amongst blood donors from the Blood Bank at Rigshospitalet, Copenhagen. This population may be selected for persons healthier than the general population in Denmark (Golding et al. 2013). Second, the sample size of the UR group was modest, so interpretation of our findings in UR should be made with caution. Third, our measure of alcohol the preceding month prior to inclusion may not be representative in patients with BD, as many patients have had a substantial overuse of alcohol preceding initiation of treatment at The Clinic of Affective Disorders, where they at the first visit were recommended alcohol abstinence for 4–12 weeks. As a result, we decided to not adjust for alcohol. Fourth, self-reported physical activity tends to be overreported and the IPAQ has in the last years been under scrutiny for not obtaining the required validity when comparing to objective measures of activity (Lee et al. 2011). However, we would expect this influencing all three groups; hence, the actual level of activity may be lower for all participants. Fifth, the PSQI does not include oversleeping, even though there are ongoing discussions as to whether it can be detrimental (Cappuccio et al. 2010; Gallicchio and Kalesan 2009; Kurina et al. 2013). Sixth, the cross-sectional nature of the design does not allow for studying possible temporal associations between the variables and the self-reported assessment rely on one time point, only. Finally, the present results are based on self-reported sleep questionnaires and not objectively measured sleep patterns, e.g. using telemonitoring devices which is recommended in future studies.

Conclusion

Patients with BD in full or partial remission reported more sleep disturbances and less moderate and vigorous physical activity than their UR and HC. The sleep disturbances and lower activity levels were associated with subsyndromal affective symptoms pointing towards the clinical importance of obtaining full remission in BD. The unaffected first-degree relatives reported sleep latency problems which may possibly be a risk marker of BD and they also used more time on moderate to vigorous physical activity. In the ongoing longitudinal BIO study, we will obtain further knowledge about sleep disturbances and patterns of physical activity preceding BD.

Acknowledgements

A special thanks to all the participants in the study for their valuable contribution and the clinicians at Copenhagen Affective Disorder Clinic, Copenhagen University Hospital, Denmark. Also, we wish to acknowledge the BIO-team for assisting in recruiting participants.

Authors’ contributions

MV and LVK conceived and designed study. LVK and MV obtained the funding. LVK applied for the Data and the Ethical permissions. KC, SS, SM, KOS recruited the patients and runned the study together with the BIO group. MV, KC and NK undertook the data extraction and the statistical analyses. NK, KC and MV drafted the manuscript drafts. All authors had substantial contributions to the design, analysis, and interpretation, and participated in manuscript drafting. All authors read and approved the final manuscript.

Funding

The study was funded by grants from the Mental Health Services, Capital Region of Denmark, The Danish Council for Independent Research, Medical Sciences (DFF—4183-00570), the A.P. Møller Foundation for the Advancement of Medical Science (15-55), Beckett-Fonden (48282), Gangstedfonden (A29594), Helsefonden (16-B-0063), Augustinusfonden (16-0083) and a scholarship from the Lundbeck Foundation.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

The BIO study has been approved by the Local Ethical Committee (H-7-2014-007) and the data agency, Capital Region of Copenhagen (RHP2015-023), and the findings will be widely disseminated at international conferences and meetings including conferences for the International Society for Bipolar Disorders and the World Federation of Societies for Biological Psychiatry and in scientific peer-reviewed papers. Trial registration number NCT02888262.

Consent for publication

Not applicable.

Competing interests

NK, KC, SS, SM, HLK, KS declare no competing interests. LVK has within recent 3 years been a consultant for Lundbeck. MV has within the last 3 years received consultancy fee from Lundbeck, Janssen/Cilag and Sunovion.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Aguib Y, Al Suwaidi J. The Copenhagen city heart study (Osterbroundersogelsen) Glob Cardiol Sci Pract. 2015;2015(3):33. doi: 10.5339/gcsp.2015.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersen LB, Schnohr P, Schroll M, Hein HO. All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med. 2000;160(11):1621–1628. doi: 10.1001/archinte.160.11.1621. [DOI] [PubMed] [Google Scholar]
  3. Baldessarini RJ, Tondo L, Baethge CJ, Lepri B, Bratti IM. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord. 2007;9(4):386–393. doi: 10.1111/j.1399-5618.2007.00385.x. [DOI] [PubMed] [Google Scholar]
  4. Bender RE, Alloy LB. Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clin Psychol Rev. 2011;31(3):383–398. doi: 10.1016/j.cpr.2011.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, et al. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. 2017;16(3):236–244. doi: 10.1002/wps.20441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
  7. Buysse DJ, Rush AJ, Reynolds CF., 3rd Clinical management of insomnia disorder. JAMA. 2017;318(20):1973–1974. doi: 10.1001/jama.2017.15683. [DOI] [PubMed] [Google Scholar]
  8. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–592. doi: 10.1093/sleep/33.5.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coello K, Kjaerstad HL, Stanislaus S, Melbye S, Faurholt-Jepsen M, Miskowiak KW, et al. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Aust N Z J Psychiatry. 2019;53(7):651–662. doi: 10.1177/0004867418815987. [DOI] [PubMed] [Google Scholar]
  10. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. doi: 10.1002/wps.20420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381(9878):1654–1662. doi: 10.1016/S0140-6736(13)60855-7. [DOI] [PubMed] [Google Scholar]
  12. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB. [DOI] [PubMed] [Google Scholar]
  13. Dagani J, Signorini G, Nielssen O, Bani M, Pastore A, Girolamo G, et al. Meta-analysis of the interval between the onset and management of bipolar disorder. Can J Psychiatry. 2017;62(4):247–258. doi: 10.1177/0706743716656607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Duffy A, Jones S, Goodday S, Bentall R. Candidate risks indicators for bipolar disorder: early intervention opportunities in high-risk youth. Int J Neuropsychopharmacol. 2015 doi: 10.1093/ijnp/pyv071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58(3):175–189. doi: 10.1016/j.biopsych.2005.05.001. [DOI] [PubMed] [Google Scholar]
  16. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009;18(2):148–158. doi: 10.1111/j.1365-2869.2008.00732.x. [DOI] [PubMed] [Google Scholar]
  17. Gold AK, Sylvia LG. The role of sleep in bipolar disorder. Nat Sci Sleep. 2016;8:207–214. doi: 10.2147/NSS.S85754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Golding J, Northstone K, Miller LL, Davey Smith G, Pembrey M. Differences between blood donors and a population sample: implications for case–control studies. Int J Epidemiol. 2013;42(4):1145–1156. doi: 10.1093/ije/dyt095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goldstein BI, Carnethon MR, Matthews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132(10):965–986. doi: 10.1161/CIR.0000000000000229. [DOI] [PubMed] [Google Scholar]
  20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. IPAQ Group. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ)—short and long forms. [Internet]. The Group; 2005. https://www.researchgate.net/file.PostFileLoader.html?id=5641f4c36143250eac8b45b7&assetKey=AS%3A294237418606593%401447163075131 [cited Feb 2018].
  22. Kantomaa MT, Tikanmaki M, Kankaanpaa A, Vaarasmaki M, Sipola-Leppanen M, Ekelund U, et al. Accelerometer-measured physical activity and sedentary time differ according to education level in young adults. PLoS ONE. 2016;11(7):e0158902. doi: 10.1371/journal.pone.0158902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009;9(7):957–966. doi: 10.1586/ern.09.31. [DOI] [PubMed] [Google Scholar]
  24. Kapczinski F, Magalhaes PV, Balanza-Martinez V, Dias VV, Frangou S, Gama CS, et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand. 2014;130:354–363. doi: 10.1111/acps.12305. [DOI] [PubMed] [Google Scholar]
  25. Keskin N, Tamam L, Ozpoyraz N. Assessment of sleep quality in bipolar euthymic patients. Compr Psychiatry. 2018;80:116–125. doi: 10.1016/j.comppsych.2017.09.012. [DOI] [PubMed] [Google Scholar]
  26. Kessing LV, Andersen PK. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135(1):51–64. doi: 10.1111/acps.12667. [DOI] [PubMed] [Google Scholar]
  27. Kessing LV, Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J, et al. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord. 2014;152–154:403–408. doi: 10.1016/j.jad.2013.10.001. [DOI] [PubMed] [Google Scholar]
  28. Kessing LV, Munkholm K, Faurholt-Jepsen M, Miskowiak KW, Nielsen LB, Frikke-Schmidt R, et al. The Bipolar Illness Onset study: research protocol for the BIO cohort study. BMJ Open. 2017;7(6):e015462. doi: 10.1136/bmjopen-2016-015462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kilbourne AM, Rofey DL, McCarthy JF, Post EP, Welsh D, Blow FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord. 2007;9(5):443–452. doi: 10.1111/j.1399-5618.2007.00386.x. [DOI] [PubMed] [Google Scholar]
  30. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–2035. doi: 10.1001/jama.2009.681. [DOI] [PubMed] [Google Scholar]
  31. Kurina LM, McClintock MK, Chen JH, Waite LJ, Thisted RA, Lauderdale DS. Sleep duration and all-cause mortality: a critical review of measurement and associations. Ann Epidemiol. 2013;23(6):361–370. doi: 10.1016/j.annepidem.2013.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017;390(10113):2643–2654. doi: 10.1016/S0140-6736(17)31634-3. [DOI] [PubMed] [Google Scholar]
  33. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International physical activity questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8:115. doi: 10.1186/1479-5868-8-115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Levenson JC, Axelson DA, Merranko J, Angulo M, Goldstein TR, Mullin BC, et al. Differences in sleep disturbances among offspring of parents with and without bipolar disorder: association with conversion to bipolar disorder. Bipolar Disord. 2015;17(8):836–848. doi: 10.1111/bdi.12345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60(5):497–502. doi: 10.1001/archpsyc.60.5.497. [DOI] [PubMed] [Google Scholar]
  36. Melo MC, Garcia RF, Linhares Neto VB, Sa MB, de Mesquita LM, de Araujo CF, et al. Sleep and circadian alterations in people at risk for bipolar disorder: a systematic review. J Psychiatr Res. 2016;83:211–219. doi: 10.1016/j.jpsychires.2016.09.005. [DOI] [PubMed] [Google Scholar]
  37. Melo MC, Daher Ede F, Albuquerque SG, de Bruin VM. Exercise in bipolar patients: a systematic review. J Affect Disord. 2016;198:32–38. doi: 10.1016/j.jad.2016.03.004. [DOI] [PubMed] [Google Scholar]
  38. Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MH. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013;170(5):542–549. doi: 10.1176/appi.ajp.2012.12030401. [DOI] [PubMed] [Google Scholar]
  39. Pancheri C, Verdolini N, Pacchiarotti I, Samalin L, Delle Chiaie R, Biondi M, et al. A systematic review on sleep alterations anticipating the onset of bipolar disorder. Eur Psychiatry. 2019;58:45–53. doi: 10.1016/j.eurpsy.2019.02.003. [DOI] [PubMed] [Google Scholar]
  40. Pedersen CB, Mors O, Bertelsen A, Waltoft BL, Agerbo E, McGrath JJ, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014;71(5):573–581. doi: 10.1001/jamapsychiatry.2014.16. [DOI] [PubMed] [Google Scholar]
  41. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–2028. doi: 10.1001/jama.2018.14854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Post RM, Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, et al. Incidence of childhood-onset bipolar illness in the USA and Europe. Br J Psychiatry. 2008;192(2):150–151. doi: 10.1192/bjp.bp.107.037820. [DOI] [PubMed] [Google Scholar]
  43. Ritter PS, Hofler M, Wittchen HU, Lieb R, Bauer M, Pfennig A, et al. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder—data from a 10-year prospective-longitudinal study among adolescents and young adults. J Psychiatr Res. 2015;68:76–82. doi: 10.1016/j.jpsychires.2015.06.005. [DOI] [PubMed] [Google Scholar]
  44. Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014;75(5):e450–e456. doi: 10.4088/JCP.13m08625. [DOI] [PubMed] [Google Scholar]
  45. Shapero BG, Weiss RB, Burke TA, Boland EM, Abramson LY, Alloy LB. Kindling of life stress in bipolar disorder: effects of early adversity. Behav Ther. 2017;48(3):322–334. doi: 10.1016/j.beth.2016.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Takaesu Y. Circadian rhythm in bipolar disorder: a review of the literature. Psychiatry Clin Neurosci. 2018;72:673–682. doi: 10.1111/pcn.12688. [DOI] [PubMed] [Google Scholar]
  47. Vancampfort D, Firth J, Schuch F, Rosenbaum S, De Hert M, Mugisha J, et al. Physical activity and sedentary behavior in people with bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2016;201:145–152. doi: 10.1016/j.jad.2016.05.020. [DOI] [PubMed] [Google Scholar]
  48. Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry. 2017;16(3):308–315. doi: 10.1002/wps.20458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Verkooijen S, van Bergen AH, Knapen SE, Vreeker A, Abramovic L, Pagani L, et al. An actigraphy study investigating sleep in bipolar I patients, unaffected siblings and controls. J Affect Disord. 2017;208:248–254. doi: 10.1016/j.jad.2016.08.076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589–593. doi: 10.1001/archpsyc.1990.01810180089012. [DOI] [PubMed] [Google Scholar]
  51. World Health Organization. International Classification of Diseases, 10th Revision (ICD-10), Genova, Schweitzerland. 2005.
  52. Yin J, Jin X, Shan Z, Li S, Huang H, Li P, et al. Relationship of sleep duration with all-cause mortality and cardiovascular events: a systematic review and dose-response meta-analysis of prospective cohort studies. J Am Heart Assoc. 2017;6(9):e005947. doi: 10.1161/JAHA.117.005947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435. doi: 10.1192/bjp.133.5.429. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Articles from International Journal of Bipolar Disorders are provided here courtesy of Springer

RESOURCES